180 related articles for article (PubMed ID: 25413414)
21. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
[TBL] [Abstract][Full Text] [Related]
22. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
Smith SMC; Bianski BM; Orr BA; Harknett G; Onar-Thomas A; Gilbertson RJ; Merchant TE; Roussel MF; Tinkle CL
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):728-737. PubMed ID: 30366006
[TBL] [Abstract][Full Text] [Related]
23. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
24. Ovarian function in survivors of childhood medulloblastoma: Impact of reduced dose craniospinal irradiation and high-dose chemotherapy with autologous stem cell rescue.
Balachandar S; Dunkel IJ; Khakoo Y; Wolden S; Allen J; Sklar CA
Pediatr Blood Cancer; 2015 Feb; 62(2):317-321. PubMed ID: 25346052
[TBL] [Abstract][Full Text] [Related]
25. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
26. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
[TBL] [Abstract][Full Text] [Related]
27. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
Ho ESQ; Barrett SA; Mullaney LM
Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
[TBL] [Abstract][Full Text] [Related]
28. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
Paulino AC
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
[TBL] [Abstract][Full Text] [Related]
29. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
[TBL] [Abstract][Full Text] [Related]
31. Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma.
Baroni LV; Freytes C; Fernández Ponce N; Oller A; Pinto N; Gonzalez A; Maldonado FR; Sampor C; Rugilo C; Lubieniecki F; Alderete D
J Neurooncol; 2021 Oct; 155(1):53-61. PubMed ID: 34505229
[TBL] [Abstract][Full Text] [Related]
32. Supine craniospinal irradiation in children: patient position modification, dose uniformity and early adverse effects.
Zaghloul MS; Eldebawy E; Attalah E; Ahmed S; Nazmy M; Aboel Anin H
Gulf J Oncolog; 2012 Jan; (11):7-15. PubMed ID: 22227539
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
[TBL] [Abstract][Full Text] [Related]
34. Postponed is not canceled: role of craniospinal radiation therapy in the management of recurrent infant medulloblastoma--an experience from the HIT-REZ 1997 & 2005 studies.
Müller K; Mynarek M; Zwiener I; Siegler N; Zimmermann M; Christiansen H; Budach W; Henke G; Warmuth-Metz M; Pietsch T; von Hoff K; von Bueren A; Bode U; Rutkowski S; Kortmann RD; Fleischhack G; Tippelt S
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1019-24. PubMed ID: 24661654
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
[TBL] [Abstract][Full Text] [Related]
36. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
[TBL] [Abstract][Full Text] [Related]
37. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation.
Song L; Wang S; Fang T; Qiu X; Wang X; Zhou X; Morse MA; Hobeika A; Wu W; Yang H; Ren J; Lyerly HK
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):479-490. PubMed ID: 33974888
[TBL] [Abstract][Full Text] [Related]
38. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
[TBL] [Abstract][Full Text] [Related]
39. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.
Eaton BR; Esiashvili N; Kim S; Patterson B; Weyman EA; Thornton LT; Mazewski C; MacDonald TJ; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Neuro Oncol; 2016 Jun; 18(6):881-7. PubMed ID: 26688075
[TBL] [Abstract][Full Text] [Related]
40. The Parotid Gland is an Underrecognized Organ at Risk for Craniospinal Irradiation.
King MT; Modlin L; Million L; Donaldson SS; Gibbs IC; Choi CY; Soltys SG
Technol Cancer Res Treat; 2016 Jun; 15(3):472-9. PubMed ID: 25948323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
